Assess response at two-week intervals during your first cycle
Obesity and Weight Studies: Published Phase 2 data (NEJM, 2023) showed up to 24.2% mean body weight reduction at 48 weeks
Successful clinical validation would not only provide a new treatment option but also retrospectively validate the CXXC5-targeting mechanism in humans, which would increase confidence in PTD-DBM as well
Gluten-, dairy-, Egg-, Peanut-, Lactose-, No artificial colors, No artificial flavors, No artificial sweeteners, No added sugar, No GMOs, No animal byproducts.,WHOLE-BODY HEALTH: AG1 fills nutrient gaps and delivers hard-to-get support for Gut Health, Digestive Regularity & Less Bloating, Energy, Immune Defenses.,THIRD-PARTY TESTING: Third-party by NSF International, a world-leading quality organization